{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:45:07Z","timestamp":1787636707872,"version":"build-2736575974"},"reference-count":46,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"unspecified","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","award":["17\/63\/121"],"award-info":[{"award-number":["17\/63\/121"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,4,25]]},"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To provide insight into how people cope with living with atrial fibrillation (AF) and taking oral anticoagulants (OACs), informing how services and healthcare delivery could be improved to offer the appropriate support patients require, thereby optimising their quality of life and well-being.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A qualitative study employing focus group discussions (FGDs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>11 primary care units in a socioeconomically deprived area of the Butantan district in S\u00e3o Paulo, Brazil.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Adults (\u226518 years) with AF purposively recruited based on sex, age and socioeconomic status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Saturation was met with three FGDs comprising seven, five and five participants, respectively. Theme one focused on self-management, where many participants discussed their methods for adhering to dietary restrictions and alternative medications, including plant-based options and specific foods, and how they modified their daily activities to reduce AF complications and symptoms. Theme two was rationality, where participants described three main ways that they cope with taking long-term medication (often warfarin): thinking that it controls their AF symptoms; it is an obligation; it prevents morbidity and premature death. Theme three was attitude and emotions, where participants described their initial reactions of shock and fear after diagnosis and ongoing emotions of sadness and frustration due to required self-management activities and regular blood tests. Theme four was medication regimen, where participants discussed difficulties with polypharmacy, changes to AF medication (particularly from non-vitamin K antagonist OACs (NOACs) to warfarin), side effects from taking warfarin and various methods of medication management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study presents three key findings with implications for patient care and support. First, the shock and fear experienced during diagnosis due to a lack of knowledge about AF suggests that improvements in public knowledge about AF are needed. Second, people with additional chronic conditions may need improved care and support, given the concern participants had regarding when and how to take their medications safely. Third, improved access to NOACs may reduce the difficulties, frustrations and concerns participants had regarding warfarin use (eg, diet, dose adjustments, self-management and monthly international normalised ratio tests).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-088226","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T14:40:14Z","timestamp":1749480014000},"page":"e088226","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Coping with a chronic condition that requires lifelong medication: a qualitative study with people living with atrial fibrillation in S\u00e3o Paulo, Brazil"],"prefix":"10.1136","volume":"15","author":[{"given":"Elisabete","family":"Paschoal","sequence":"first","affiliation":[{"name":"Center for Clinical and Epidemiological Research, Universidade de Sao Paulo, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo D","family":"Olmos","sequence":"additional","affiliation":[{"name":"Center for Clinical and Epidemiological Research, Universidade de Sao Paulo, Sao Paulo, Brazil"},{"name":"Universidade de S\u00e3o Paulo, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3905-5477","authenticated-orcid":false,"given":"Tiffany E","family":"Gooden","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo A","family":"Lotufo","sequence":"additional","affiliation":[{"name":"ELSA Brasil Cohort Study, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela","family":"Bensenor","sequence":"additional","affiliation":[{"name":"Center for Clinical and Epidemiological Research, Universidade de Sao Paulo, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6224-2115","authenticated-orcid":false,"given":"Kate","family":"Jolly","sequence":"additional","affiliation":[{"name":"University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y H","family":"Lip","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"},{"name":"Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool, Merseyside, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Neil Thomas","sequence":"additional","affiliation":[{"name":"University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8796-4114","authenticated-orcid":false,"given":"Sheila","family":"Greenfield","sequence":"additional","affiliation":[{"name":"University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5604-9378","authenticated-orcid":false,"given":"Deirdre","family":"Lane","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool, Merseyside, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1076-5210","authenticated-orcid":false,"given":"Alessandra C","family":"Goulart","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, School of Public Health, Universidade de Sao Paulo, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"key":"2025121600522893000_15.6.e088226.1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9566.1991.tb00522.x"},{"key":"2025121600522893000_15.6.e088226.2","doi-asserted-by":"crossref","DOI":"10.1093\/geroni\/igad141","article-title":"The Need to Appear Healthy: Concealment of Chronic Illness, Privacy, and Self-Sufficiency Among Chronically Ill Older Nigerians","volume":"8","author":"Mahmoud","year":"2024","journal-title":"Innov Aging"},{"key":"2025121600522893000_15.6.e088226.3","doi-asserted-by":"crossref","DOI":"10.1080\/17482631.2020.1857579","article-title":"Non-visible disease, the hidden disruptive experiences of chronic illness in adversity","volume":"15","author":"Estecha Querol","year":"2020","journal-title":"Int J Qual Stud Health Well-being"},{"key":"2025121600522893000_15.6.e088226.4","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.113.002329"},{"key":"2025121600522893000_15.6.e088226.5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-12-200706190-00007"},{"key":"2025121600522893000_15.6.e088226.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62343-0"},{"key":"2025121600522893000_15.6.e088226.7","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-020-01509-x","article-title":"Concomitant use of direct oral anticoagulants and aspirin versus direct oral anticoagulants alone in atrial fibrillation and flutter: a retrospective cohort","volume":"20","author":"Said","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"2025121600522893000_15.6.e088226.8","first-page":"554","article-title":"The efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and coronary artery disease: A meta-analysis of randomized trials","volume":"8","author":"Zelniker","year":"2019","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2025121600522893000_15.6.e088226.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00264-7"},{"key":"2025121600522893000_15.6.e088226.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.01.011"},{"key":"2025121600522893000_15.6.e088226.11","doi-asserted-by":"crossref","first-page":"I13","DOI":"10.1093\/eurheartj\/suaa104","article-title":"Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation","volume":"22","author":"Diener","year":"2020","journal-title":"Eur Heart J Suppl"},{"key":"2025121600522893000_15.6.e088226.12","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.583311","article-title":"Effectiveness and Safety of Oral Anticoagulants in Older Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis","volume":"11","author":"Grymonprez","year":"2020","journal-title":"Front Pharmacol"},{"key":"2025121600522893000_15.6.e088226.13","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.clinthera.2017.05.358","article-title":"Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses","volume":"39","author":"Almutairi","year":"2017","journal-title":"Clin Ther"},{"key":"2025121600522893000_15.6.e088226.14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/suaa181"},{"key":"2025121600522893000_15.6.e088226.15","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023907","article-title":"Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA-AF Phase III Registry","volume":"11","author":"Bayer","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2025121600522893000_15.6.e088226.16","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.thromres.2014.03.052","article-title":"Impact of short periods with worsened or improved INR control on life expectancy and QALYs in patients with atrial fibrillation","volume":"133","author":"Les\u00e9n","year":"2014","journal-title":"Thromb Res"},{"key":"2025121600522893000_15.6.e088226.17","doi-asserted-by":"crossref","DOI":"10.1186\/s12875-016-0574-0","article-title":"Patients\u2019 and physicians\u2019 perceptions and attitudes about oral anticoagulation and atrial fibrillation: a qualitative systematic review","volume":"18","author":"Mas Dalmau","year":"2017","journal-title":"BMC Fam Pract"},{"key":"2025121600522893000_15.6.e088226.18","article-title":"Patients\u2019 Perspectives on Commencing Oral Anticoagulants in Atrial Fibrillation: An Exploratory Qualitative Descriptive Study","volume":"11","author":"Gebreyohannes","year":"2023","journal-title":"Pharmacy (Basel)"},{"key":"2025121600522893000_15.6.e088226.19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/2041-210X.12860","article-title":"The use of focus group discussion methodology: insights from two decades of application in conservation","volume":"9","author":"O.Nyumba","year":"2018","journal-title":"Methods Ecol Evol"},{"key":"2025121600522893000_15.6.e088226.20","doi-asserted-by":"crossref","DOI":"10.1080\/16549716.2023.2231763","article-title":"Generalisability of and lessons learned from a mixed-methods study conducted in three low- and middle-income countries to identify care pathways for atrial fibrillation","volume":"16","author":"Gooden","year":"2023","journal-title":"Glob Health Action"},{"key":"2025121600522893000_15.6.e088226.21","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1093\/eurheartj\/ehz648","article-title":"The National Institute for Health Research (NIHR) Global Health Research Group on Atrial Fibrillation management","volume":"40","author":"Lip","year":"2019","journal-title":"Eur Heart J"},{"key":"2025121600522893000_15.6.e088226.22","unstructured":"United Nations . World economic situation and prospects 2020. New York United Nations; 2020. Available: https:\/\/www.un.org\/development\/desa\/dpad\/wp content\/uploads\/sites\/45\/WESP2020_FullReport.pdf"},{"key":"2025121600522893000_15.6.e088226.23","article-title":"Free access to medicines for the treatment of chronic diseases in Brazil","volume":"50","author":"Tavares","year":"2016","journal-title":"Rev Saude Publica"},{"key":"2025121600522893000_15.6.e088226.24","unstructured":"City population BUTANT\u00c3 Municipal District in S\u00e3o Paulo. Available: https:\/\/www.citypopulation.de\/en\/brazil\/saopaulocity\/_\/355030812__butant%C3%A3\/ [Accessed 04 Jan 2023]."},{"key":"2025121600522893000_15.6.e088226.25","first-page":"602","article-title":"Prevalence of electrocardiographic findings in elderly individuals: the Sao Paulo aging & health study","volume":"93","author":"Kawabata-Yoshihara","year":"2009","journal-title":"Arq Bras Cardiol"},{"key":"2025121600522893000_15.6.e088226.26","doi-asserted-by":"publisher","DOI":"10.1007\/s11135-017-0574-8"},{"key":"2025121600522893000_15.6.e088226.27","first-page":"17","article-title":"An overview of content analysis","volume":"7","author":"Stemler","year":"2000","journal-title":"Practical Assessment, Research, and Evaluation"},{"key":"2025121600522893000_15.6.e088226.28","unstructured":"Salda\u00f1a J . The coding manual for qualitative researchers. SAGE Publications Ltd, 2021."},{"key":"2025121600522893000_15.6.e088226.29","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0000000000000388"},{"key":"2025121600522893000_15.6.e088226.30","unstructured":"Gooden T , Goulart AC , Varella AC , et al . Data from: Focus group discussions with people living with atrial fibrillation in Brazil. Figshare dataset. Available: https:\/\/doi.org\/10.6084\/m9.figshare.24204936.v1 [Accessed 27 Sep 2023]."},{"key":"2025121600522893000_15.6.e088226.31","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw233"},{"key":"2025121600522893000_15.6.e088226.32","doi-asserted-by":"crossref","DOI":"10.1186\/s12875-021-01590-x","article-title":"Patients\u2019 and clinicians\u2019 perceptions of oral anticoagulants in atrial fibrillation: a systematic narrative review and meta-analysis","volume":"22","author":"Osasu","year":"2021","journal-title":"BMC Fam Pract"},{"key":"2025121600522893000_15.6.e088226.33","doi-asserted-by":"publisher","DOI":"10.1586\/erp.09.48"},{"key":"2025121600522893000_15.6.e088226.34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4321\/S1886-36552009000200008","article-title":"Balancing risk versus benefit: the elderly patient\u2019s perspective on warfarin therapy","volume":"7","author":"Bajorek","year":"2009","journal-title":"Pharm Pract (Granada)"},{"key":"2025121600522893000_15.6.e088226.35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.5694\/j.1326-5377.2007.tb00856.x","article-title":"Management of warfarin in atrial fibrillation: views of health professionals, older patients and their carers","volume":"186","author":"Bajorek","year":"2007","journal-title":"Med J Aust"},{"key":"2025121600522893000_15.6.e088226.36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.thromres.2017.12.021","article-title":"Exploration of adherence and patient experiences with DOACs one year after switching from vitamin-K antagonists- insights from the switching study","volume":"162","author":"Bartoli-Abdou","year":"2018","journal-title":"Thromb Res"},{"key":"2025121600522893000_15.6.e088226.37","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2296-5-15","article-title":"Patients\u2019 perspectives on taking warfarin: qualitative study in family practice","volume":"5","author":"Dantas","year":"2004","journal-title":"BMC Fam Pract"},{"key":"2025121600522893000_15.6.e088226.38","unstructured":"Academy of Medical Sciences . Multimorbidity: a priority for global health research. 2018. Available: https:\/\/acmedsci.ac.uk\/file-download\/82222577 [Accessed 22 Nov 2023]."},{"key":"2025121600522893000_15.6.e088226.39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0292463","article-title":"Identifying and understanding the care pathway of patients with atrial fibrillation in Brazil and the impact of the COVID-19 pandemic: A mixed-methods study","volume":"18","author":"Goulart","year":"2023","journal-title":"PLoS One"},{"key":"2025121600522893000_15.6.e088226.40","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7425.1219"},{"key":"2025121600522893000_15.6.e088226.41","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000665"},{"key":"2025121600522893000_15.6.e088226.42","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-022-08440-1","article-title":"Healthcare provider and patient perspectives on access to and management of atrial fibrillation in the Northern Province, Sri Lanka: a rapid evaluation of barriers and facilitators to care","volume":"22","author":"Sheron","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"2025121600522893000_15.6.e088226.43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232484","article-title":"Clinicians\u2019 views and experiences of prescribing oral anticoagulants for stroke prevention in atrial fibrillation: A qualitative meta-synthesis","volume":"15","author":"Pritchett","year":"2020","journal-title":"PLoS One"},{"key":"2025121600522893000_15.6.e088226.44","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-022-02927-9","article-title":"Health care professionals\u2019 perceptions about atrial fibrillation care in the Brazilian public primary care system: a mixed-methods study","volume":"22","author":"Paschoal","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"2025121600522893000_15.6.e088226.45","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002895","article-title":"Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True?: A Systematic Review","volume":"95","author":"Violi","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2025121600522893000_15.6.e088226.46","doi-asserted-by":"crossref","DOI":"10.1590\/1983-1447.2019.20190083","article-title":"Beliefs related to diet adherence of patients treated with oral anticoagulants","volume":"40","author":"Oliveira","year":"2019","journal-title":"Rev Gaucha Enferm"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-088226","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T08:52:38Z","timestamp":1765875158000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-088226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,9]]},"published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1136\/bmjopen-2024-088226"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-088226","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}